USANA Health Sciences, Inc. (USNA)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,135 | 1,186 | 999 | 921 | 855 | 925 | 913 | 925 |
| Operating profit | $m | 51 | 12 | ||||||
| Net profit | $m | 125 | 117 | 69 | 64 | 42 | 11 | -22 | 32 |
| EPS reported | $ | 0.58 | -1.21 | ||||||
| Operating cashflow per share | $ | 1.20 | 0.90 | ||||||
| Capex per share | $ | 0.74 | 0.74 | ||||||
| FCF per share | $ | 0.46 | 0.16 | ||||||
| Free cash flow | $m | 9 | 16 | ||||||
| Net debt | $m | -144 | -169 | ||||||
| Book value equity | $m | 533 | 526 | ||||||
| Book value per share | $ | 28.70 | 28.47 | ||||||
| Number of shares | m | 18.57 | 18.49 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 33.52 | - | ||||||
| P/B LTM | x | 0.68 | 0.49 | ||||||
| P/S LTM | x | 0.39 | 0.29 | ||||||
| P/FCF LTM | x | 42.35 | 89.98 | ||||||
| EV/EBITDA LTM | x | 2.64 | 3.60 | ||||||
| EV/Sales LTM | x | 0.23 | 0.13 | ||||||
| Earnings Yield LTM | % | +2.98% | -8.31% | ||||||
| FCF Yield | % | +2.36% | +5.98% | ||||||
| Quality | |||||||||
| ROE | % | +2.02% | -4.15% | ||||||
| ROIC | % | +2.24% | -22.41% | ||||||
| Operating margin | % | +5.50% | +1.35% | ||||||
| Gross margin | % | +78.29% | +77.45% | ||||||
| FCF/Sales | % | +0.92% | +0.32% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -73.52% | - | ||||||
| Sales Growth YoY | % | +8.28% | +6.89% | ||||||
| Net Income Growth YoY | % | -74.40% | - | ||||||
| FCF Growth | % | -83.26% | -68.71% | ||||||
| Operating Profit Growth | % | -23.31% | -81.38% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.61 | - | ||||||
| Net Debt/EBITDA | x | -1.76 | -4.56 | ||||||
| EBIT/Net interest | x | 60.41 | 29.98 | ||||||
| Net debt/market cap | % | +3.88% | +5.25% | ||||||
| Net debt/Equity | x | -0.27 | -0.32 | ||||||
| Gross debt/equity | x | 0.03 | 0.00 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
USANA Health Sciences, Inc. (USNA)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free